Literature DB >> 1248270

Detection of unstable angina by 99m technetium pyrophosphate myocardial scintigraphy.

A M Abdulla, M I Canedo, B C Cortez, K D McGinnis, S K Wilhelm.   

Abstract

99mTechnetium stannous pyrophosphate has been shown to accumulate in acutely infarcted myocardium. To determine if the isotope is also taken up by severely ischemic, but not necrotic myocardium, we performed myocardial scintigraphic studies in 17 patients with chest pains. Seven of the patients satisfied conventional clinical, electrographic, and laboratory criteria for the diagnosis of unstable angina and showed no electrocardiographic or enzymatic evidence of myocardial necrosis. Five of these seven patients with unstable angina demonstrated abnormal localized patterns, and one showed a borderline picture. Myocardial scintiscans were normal in all of a control group of ten patients with stable angina. Thus, scanning with 99mtechnetium stannous pyrophosphate is shown to be of value in the objective demonstration of myocardial abnormality in unstable angina.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1248270     DOI: 10.1378/chest.69.2.168

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Myocardial scintigraphy with infarct-avid tracers.

Authors:  B L Holman; J Wynne
Journal:  Cardiovasc Radiol       Date:  1979-09

2.  Assessment of diagnostic value of technetium-99m pyrophosphate myocardial scintigraphy in 80 patients with possible acute myocardial infarction.

Authors:  W F Walsh; H B Karunaratne; L Resnekov; H R Fill; P V Harper
Journal:  Br Heart J       Date:  1977-09

3.  Technetium-99m stannous pyrophosphate scintigraphy in patients with calcification within the cardiac silhouette.

Authors:  R W Wald; L Sternberg; V F Huckell; H M Staniloff; D H Feiglin; J E Morch
Journal:  Br Heart J       Date:  1978-05

4.  Limitation of infarct size with preconditioning and calcium antagonist (diltiazem): difference in 99mTc-PYP uptake in the myocardium.

Authors:  K Okuda; R Nohara; M Ogino; N Tamaki; J Konishi; M Fujita; S Sasayama
Journal:  Ann Nucl Med       Date:  1996-05       Impact factor: 2.668

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.